Skip to main content
Top
Published in: Indian Journal of Pediatrics 1/2022

01-01-2022 | SARS-CoV-2 | Original Article

Clinical Profile of COVID-19 Illness in Children—Experience from a Tertiary Care Hospital

Authors: Preeti Singh, Karanvir Attri, Deonath Mahto, Virendra Kumar, Dipti Kapoor, Anju Seth, Varinder Singh, Harish Pemde, Praveen Kumar, Ravitanaya Sodani, Ankita Goel

Published in: Indian Journal of Pediatrics | Issue 1/2022

Login to get access

Abstract

Objective

To detail clinical profile and outcome in children infected with SARS-CoV-2.

Methods

This retrospective study was undertaken at a tertiary care pediatric teaching hospital in Northern India. The data on clinical characteristics and outcome of children (< 18 y) with COVID-19 illness from April 2020–October 2020 were reviewed and analyzed.

Results

A total of 2919 children with suspected severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) illness were tested for novel COVID-19 virus in the flu emergency (n = 1744), severe acute respiratory infection (SARI) ward (n = 825), and non-COVID area (n = 350) of the hospital. 8.73% (255/2919) children tested positive for SARS-CoV-2 infection. Of the 255 positive cases, 144 (56.47%) were managed on an outpatient basis and 100 (59 boys) required admission in COVID ward. The mortality rate of patients with SARS-CoV-2 was 11.4% (29/255). Majority of children admitted with COVID-19 had severe to critical illness due to the presence of malnutrition and underlying comorbidities.

Conclusions

Children of all age groups were susceptible to COVID-19 illness with a slight male preponderance. Amongst infected, two-third were asymptomatic or had mild symptoms that required outpatient management and home isolation. The adverse outcomes were more commonly seen in infants and children > 10 y of age with malnutrition and comorbid illness.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan. China JAMA. 2020;323:1061–9.CrossRef Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan. China JAMA. 2020;323:1061–9.CrossRef
2.
go back to reference Gupta N, Praharaj I, Bhatnagar T, et al. Severe acute respiratory illness surveillance for coronavirus disease 2019, India, 2020. Indian J Med Res. 2020;151:236–40.CrossRef Gupta N, Praharaj I, Bhatnagar T, et al. Severe acute respiratory illness surveillance for coronavirus disease 2019, India, 2020. Indian J Med Res. 2020;151:236–40.CrossRef
3.
go back to reference Stokes EK, Zambrano LD, Anderson KN, et al. Coronavirus Disease 2019 case surveillance – United States, January 22–May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:759–65.CrossRef Stokes EK, Zambrano LD, Anderson KN, et al. Coronavirus Disease 2019 case surveillance – United States, January 22–May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:759–65.CrossRef
4.
go back to reference Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID–19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA. 2020;323:1239–42.CrossRef Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID–19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA. 2020;323:1239–42.CrossRef
5.
go back to reference Han MS, Choi EH, Chang SH, et al. Clinical Characteristics and Viral RNA Detection in Children with coronavirus disease 2019 in the Republic of Korea. JAMA Pediatr. 2021;175:73–80.CrossRef Han MS, Choi EH, Chang SH, et al. Clinical Characteristics and Viral RNA Detection in Children with coronavirus disease 2019 in the Republic of Korea. JAMA Pediatr. 2021;175:73–80.CrossRef
6.
go back to reference Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145:e20200702.CrossRef Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145:e20200702.CrossRef
7.
go back to reference Balasubramanian S, Nagendran TM, Ramachandran B, Ramanan AV. Hyper–inflammatory syndrome in a child with covid–19 treated successfully with intravenous immunoglobulin and tocilizumab. Indian Pediatr. 2020;57:681–3.CrossRef Balasubramanian S, Nagendran TM, Ramachandran B, Ramanan AV. Hyper–inflammatory syndrome in a child with covid–19 treated successfully with intravenous immunoglobulin and tocilizumab. Indian Pediatr. 2020;57:681–3.CrossRef
8.
go back to reference Dhanalakshmi K, Venkataraman A, Balasubramanian S, et al. Epidemiological and clinical profile of pediatric inflammatory multisystem syndrome – temporally associated with SARS–CoV–2 (PIMS–TS) in Indian children. Indian Pediatr. 2020;57:1010–4.CrossRef Dhanalakshmi K, Venkataraman A, Balasubramanian S, et al. Epidemiological and clinical profile of pediatric inflammatory multisystem syndrome – temporally associated with SARS–CoV–2 (PIMS–TS) in Indian children. Indian Pediatr. 2020;57:1010–4.CrossRef
10.
go back to reference Revised Guidelines on Clinical Management of COVID – 19 Government of India. Ministry of Health & Family Welfare Directorate General of Health Services (EMR Division). Revised Guidelines on Clinical Management of COVID – 19 Government of India. Ministry of Health & Family Welfare Directorate General of Health Services (EMR Division).
11.
go back to reference Weiss SL, Peters MJ, Alhazzani W, et al. Surviving Sepsis campaign international guidelines for the management of septic shock and sepsis–associated organ dysfunction in children. PediatrCrit Care Med. 2020;21:e52–106.CrossRef Weiss SL, Peters MJ, Alhazzani W, et al. Surviving Sepsis campaign international guidelines for the management of septic shock and sepsis–associated organ dysfunction in children. PediatrCrit Care Med. 2020;21:e52–106.CrossRef
12.
go back to reference Nakra NA, Blumberg DA, Herrera-Guerra A, Lakshminrusimha S. Multi–system inflammatory syndrome in children (MIS–C) following SARS–CoV–2 infection: review of clinical presentation, hypothetical pathogenesis, and proposed management. Children (Basel). 2020;7:69. Nakra NA, Blumberg DA, Herrera-Guerra A, Lakshminrusimha S. Multi–system inflammatory syndrome in children (MIS–C) following SARS–CoV–2 infection: review of clinical presentation, hypothetical pathogenesis, and proposed management. Children (Basel). 2020;7:69.
14.
go back to reference Choi S-H, Kim HW, Kang J–M, Kim DH, Cho EY. Epidemiology and clinical features of coronavirus disease, in children. Clin Exp Pediatr. 2019;2020(63):125–32. Choi S-H, Kim HW, Kang J–M, Kim DH, Cho EY. Epidemiology and clinical features of coronavirus disease, in children. Clin Exp Pediatr. 2019;2020(63):125–32.
15.
go back to reference Shekerdemian LS, Mahmood NR, Wolfe KK, et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID–19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr. 2020;174:868–73.CrossRef Shekerdemian LS, Mahmood NR, Wolfe KK, et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID–19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr. 2020;174:868–73.CrossRef
16.
go back to reference Liguoro I, Pilotto C, Bonanni M, et al. SARS–COV–2 infection in children and newborns: a systematic review. Eur J Pediatr. 2020;179:1029–46.CrossRef Liguoro I, Pilotto C, Bonanni M, et al. SARS–COV–2 infection in children and newborns: a systematic review. Eur J Pediatr. 2020;179:1029–46.CrossRef
17.
go back to reference Banerjee S, Guha A, Das A, Nandi M, Mondal R. A Preliminary Report of COVID–19 in Children in India. Indian Pediatr. 2020;57:963–4.CrossRef Banerjee S, Guha A, Das A, Nandi M, Mondal R. A Preliminary Report of COVID–19 in Children in India. Indian Pediatr. 2020;57:963–4.CrossRef
18.
go back to reference Lu X, Zhang L, Du H, et al. SARS–CoV–2 infection in children. N Engl J Med. 2020;382:1663–5.CrossRef Lu X, Zhang L, Du H, et al. SARS–CoV–2 infection in children. N Engl J Med. 2020;382:1663–5.CrossRef
19.
go back to reference Meena J, Yadav J, Saini L, Yadav A, Kumar J. Clinical features and outcome of SARS–CoV–2 infection in children: a systematic review and meta–analysis. Indian Pediatr. 2020;57:820–6.CrossRef Meena J, Yadav J, Saini L, Yadav A, Kumar J. Clinical features and outcome of SARS–CoV–2 infection in children: a systematic review and meta–analysis. Indian Pediatr. 2020;57:820–6.CrossRef
20.
go back to reference Hoang A, Chorath K, Moreira A, et al. COVID–19 in 7780 pediatric patients: a systematic review. Eclinical Medicine. 2020;24:100433.CrossRef Hoang A, Chorath K, Moreira A, et al. COVID–19 in 7780 pediatric patients: a systematic review. Eclinical Medicine. 2020;24:100433.CrossRef
21.
go back to reference Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID–19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis. 2020;20:689–96.CrossRef Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID–19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis. 2020;20:689–96.CrossRef
22.
go back to reference Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–13.CrossRef Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–13.CrossRef
23.
go back to reference Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al. Clinical, laboratory and imaging features of COVID–19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623.CrossRef Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al. Clinical, laboratory and imaging features of COVID–19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623.CrossRef
24.
go back to reference Patel NA. Pediatric COVID–19: a systematic review of the literature. Am J Otolaryngol. 2020;41:102573.CrossRef Patel NA. Pediatric COVID–19: a systematic review of the literature. Am J Otolaryngol. 2020;41:102573.CrossRef
25.
go back to reference Acharyya BC, Acharyya S, Das D. Novel coronavirus, mimicking kawasaki disease in an infant. Indian Pediatr. 2020;57:753–4.CrossRef Acharyya BC, Acharyya S, Das D. Novel coronavirus, mimicking kawasaki disease in an infant. Indian Pediatr. 2020;57:753–4.CrossRef
26.
go back to reference Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe kawasaki–like disease at the Italian epicentre of the SARS–CoV–2 epidemic: an observational cohort study. Lancet. 2020;395:1771–8.CrossRef Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe kawasaki–like disease at the Italian epicentre of the SARS–CoV–2 epidemic: an observational cohort study. Lancet. 2020;395:1771–8.CrossRef
27.
go back to reference Viner RM, Whittaker E. Kawasaki–like disease: emerging complication during the COVID–19 pandemic. Lancet. 2020;395:1741–3.CrossRef Viner RM, Whittaker E. Kawasaki–like disease: emerging complication during the COVID–19 pandemic. Lancet. 2020;395:1741–3.CrossRef
Metadata
Title
Clinical Profile of COVID-19 Illness in Children—Experience from a Tertiary Care Hospital
Authors
Preeti Singh
Karanvir Attri
Deonath Mahto
Virendra Kumar
Dipti Kapoor
Anju Seth
Varinder Singh
Harish Pemde
Praveen Kumar
Ravitanaya Sodani
Ankita Goel
Publication date
01-01-2022
Publisher
Springer India
Published in
Indian Journal of Pediatrics / Issue 1/2022
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-021-03822-5

Other articles of this Issue 1/2022

Indian Journal of Pediatrics 1/2022 Go to the issue